Skip to main content

MoneyWorks4Me

Lupin informs about press release

15 Oct 2024 Evaluate
Lupin has informed that it enclosed a Press Release as regards, launch of the first generic version of Pred Forte®(Prednisolone Acetate) Ophthalmic Suspension USP, 1% in the United States.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..